Gould Robert J

CIK 00015770343 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001577034

Recent Transactions

50 trades

Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2026-01-02$11.87/sh−15,000→ 469,864 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2025-11-19$11.03/sh−15,000→ 484,864 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2025-06-26+36,000→ 36,000 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2024-06-17+30,000→ 30,000 total
Award
Turnstone Biologics Corp.
Stock Option (Right to Buy)
2024-06-03+12,770→ 12,770 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2023-06-27+30,000→ 30,000 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2023-01-13$15.00/sh−6,766→ 499,864 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-27+19,000→ 19,000 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-07−71,435→ 86,523 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-07$8.09/sh−71,435→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-07$7.84/sh+71,435→ 578,065 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-06$8.10/sh−24,382→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-06$7.84/sh+24,382→ 531,012 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-06−24,382→ 157,958 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-03−25,551→ 182,340 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-03$7.95/sh−25,551→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-03$7.84/sh+25,551→ 532,181 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-02$7.92/sh−16,689→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-02−16,689→ 207,891 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-06-02$7.84/sh+16,689→ 523,319 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-04-07$7.84/sh+5,631→ 512,261 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-04-07−5,631→ 224,580 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-04-07$24.02/sh−5,631→ 506,630 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-04-05$24.26/sh−52,552→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-04-05$7.84/sh+52,552→ 559,182 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-04-05−52,552→ 230,211 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-04-04−7,235→ 282,763 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-04-04$7.84/sh+7,235→ 513,865 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-04-04$24.02/sh−7,235→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-04-01−34,464→ 289,998 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-04-01$24.03/sh−34,464→ 506,630 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2022-04-01$7.84/sh+34,464→ 541,094 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2021-03-16$12.43/sh−789→ 506,630 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2021-03-15$12.13/sh−9,211→ 507,419 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2021-02-16$14.19/sh−6,542→ 518,303 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2021-02-16$14.56/sh−1,673→ 516,630 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2021-02-02+269,390→ 269,390 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2021-01-20$12.08/sh−10,000→ 524,845 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-07-08$20.00/sh−2,500→ 534,845 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-06-25$20.80/sh−2,500→ 537,345 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-06-09$20.00/sh−156→ 539,845 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-06-05$20.17/sh−3,433→ 540,001 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-06-04$20.04/sh−1,300→ 543,434 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-06-03$20.13/sh−1,500→ 544,734 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-06-02$20.00/sh−2,797→ 546,234 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-06-01$20.00/sh−5→ 549,031 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-05-29$20.08/sh−1,390→ 549,036 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-05-28$20.01/sh−1,919→ 550,426 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-05-26$20.00/sh−2,500→ 552,345 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-02-19$20.00/sh−2,500→ 554,845 total

Companies

Recent Filings

Address

C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139

View on SEC.gov